SCHEMBL6619372

SCHEMBL6619372

CC(C)N1C(=O)N(c2c(Cl)cccc2Cl)Cc2cnc(S(C)(=O)=O)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 3/20 0.42
MAPK14 Q16539 2/20 0.39
LCK P06239 1/20 0.39
TP53 P04637 5/20 0.36
MAPT P10636 5/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 3/20 0.34
SIK2 Q9H0K1 3/20 0.33
TLR9 Q9NR96 6/20 0.33
NPC1 O15118 5/20 0.33
RAB9A P51151 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MITF O75030 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
S1PR4 O95977 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231241 0.86 FGFR4 (0.52) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6619490 0.83 MAPK14 (0.42) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6619216 0.82 MAPK14 (0.42) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6619641 0.82 FGFR4 (0.45) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6618524 0.81 FGFR4 (0.44) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6619197 0.80 FGFR4 (0.47) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6620496 0.77 FGFR4 (0.39) FGFR4MAPK14LCKMAPTHTT
SCHEMBL6619217 0.77 FGFR4 (0.36) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6622980 0.76 MAPK14 (0.43) FGFR4MAPK14LCKTP53MAPT
SCHEMBL6622657 0.75 FGFR4 (0.42) FGFR4MAPK14LCKFGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123295-B1 BICYCLIC NITROGEN HETEROCYCLES HOFFMANN LA ROCHE (CH) 2004-09-29 EP disclosed
EP-1123295-A1 BICYCLIC NITROGEN HETEROCYCLES F. HOFFMANN-LA ROCHE AG (CH) 2001-08-16 EP disclosed
US-6150373-A AMINO-SUBSTITUTED DIHYDROPYRIMIDO(4,5-D)PYRIMIDINONE DERIVATIVES; INHIBITORS OF THE T-CELL TYROSINE KINASE P56LCK; IMMUNOSUPPRESSANTS; ANTIINFLAMMATORY/-CARCINOGENIC AGENTS; BRONCHOPULMONARY, DERMATOLOGICAL AND CARDIOVASCULAR DISORDERS HOFFMANN-LA ROCHE INC. (US) 2000-11-21 US disclosed
WO-2000024744-A1 BICYCLIC NITROGEN HETEROCYCLES F. HOFFMANN-LA ROCHE AG (CH) 2000-05-04 WO disclosed